Acute and chronic chorioamnionitis and the risk of perinatal human immunodeficiency virus-1 transmission

Am J Obstet Gynecol. 2006 Jan;194(1):174-81. doi: 10.1016/j.ajog.2005.06.081.

Abstract

Objective: This study was undertaken to examine the prevalence of acute and chronic chorioamnionitis among women infected with human immunodeficiency virus-1 (HIV-1) and to determine the relative contribution of each to perinatal HIV-1 transmission.

Study design: In 227 HIV-infected women receiving intrapartum/neonatal nevirapine prophylaxis, we examined associations between fetal membrane histology, cord blood interleukin-6 (IL-6), and perinatal HIV-1 transmission.

Results: Acute chorioamnionitis was present in 122 of 227 specimens; chronic chorioamnionitis in 64 of 227. There was a positive correlation between acute chorioamnionitis and labor length (r = 0.208; P = .002), time of ruptured membrane (r = 0.177; P = .008), and cord IL-6 (r = 0.390; P < .001). Chronic chorioamnionitis was associated with high viral load (P = .05) and low cord IL-6 (P < .001). Severe chronic chorioamnionitis was associated with intrauterine HIV-1 transmission (odds ratio [OR] = 7.61; 95% CI = 1.04-85.5), but no correlation was demonstrated between acute chorioamnionitis and vertical transmission.

Conclusion: In a setting of high perinatal nevirapine use, acute chorioamnionitis was not associated with vertical HIV-1 transmission. Risk for intrauterine transmission increased significantly when chronic chorioamnionitis was present.

Publication types

  • Controlled Clinical Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adult
  • Anti-HIV Agents / therapeutic use
  • Chorioamnionitis / epidemiology*
  • Chronic Disease
  • Female
  • Fetal Blood
  • HIV Infections / blood
  • HIV Infections / drug therapy
  • HIV Infections / epidemiology*
  • HIV Infections / transmission*
  • HIV-1*
  • Humans
  • Infectious Disease Transmission, Vertical* / prevention & control
  • Interleukin-6 / blood
  • Labor, Obstetric
  • Maternal-Fetal Exchange
  • Nevirapine / therapeutic use
  • Predictive Value of Tests
  • Pregnancy
  • Prevalence
  • Risk Assessment
  • Time Factors

Substances

  • Anti-HIV Agents
  • Interleukin-6
  • Nevirapine